NASDAQ | ETF
The fund normally invests at least 80% of assets in securities of disruptive medicine companies.
Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers.
Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 5.04% |
| TXG | 10X Genomics Inc | Healthcare | Health Information Services | 4.46% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 3.96% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.84% |
| LFST | Lifestance Health Group Inc | Healthcare | Medical Care Facilities | 3.14% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.09% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 2.99% |
| UMRX | Cogent Biosciences Inc | Healthcare | Biotechnology | 2.97% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 2.84% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 2.61% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 2.34% |
| MASI | Masimo Corporation | Healthcare | Medical Devices | 2.33% |
| TECH | Bio-Techne Corp | Healthcare | Biotechnology | 2.32% |
| KYMR | Kymera Therapeutics Inc | Healthcare | Biotechnology | 2.28% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 2.23% |
| UCB | UCB SA | Healthcare | Biotechnology | 2.02% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 1.88% |
| DIM | Sartorius Stedim Biotech SA | Healthcare | Medical Instruments & Supplies | 1.87% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.87% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 1.83% |